Compelling Increase in Parvovirus B19 Infections: Analysis of Molecular Diagnostic Trends (2019–2024)
Viruses · 04.04.2025 · 17 (4) · 523
DOI: 10.3390/v17040523 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 04.04.2025. Verfasst von Flora Marzia Liotti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Scienze di Laboratorio ed Ematologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy. Hauptthemen laut MEDLINE: Parvovirus B19, Human, Parvoviridae Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Human parvovirus B19 (B19V) follows a well-documented cyclical epidemiology, with peaks occurring every 3–4 years. However, recent reports indicate an unusual resurgence in B19V infections across multiple countries, prompting increased surveillance. This study analyzed molecular diagnostic assay results from 826 unique-patient samples tested for B19V DNA between 2019 and 2024 at a large Italian tertiary-care hospital, covering pre-, during, and post-COVID-19 years. Overall, 80 of 826 patients (9.7%) tested positive for B19V DNA. A significant increase in positivity was observed in 2024 (23.4%), with a peak in May, representing an eightfold rise compared to 2019–2020. Despite this surge, the distribution of positive cases across population categories remained consistent with previous years, with 32 of 80 (40.0%) positive samples from pregnant women and 27 of 80 (33.8%) from hematology/oncology patients. Among 66 B19V DNA-positive patients with available serology, 4 of 66 (6.1%)—all immunocompromised—lacked detectable IgM/IgG despite high B19V DNA levels (7.8 log10 IU/mL). These findings highlight the importance of integrating molecular and serological diagnostics, particularly in high-risk populations. Given the potential impact of the COVID-19 pandemic on B19V circulation, continued surveillance is essential to determine whether this resurgence represents a temporary fluctuation or a sustained epidemiological shift.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dipartimento di Scienze di Laboratorio ed Ematologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
- Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
- Unità Operativa "Medicina di Precisione in Microbiologia Clinica", Direzione Scientifica, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
ORCID-Profile: Flora Marzia Liotti, Maurizio Sanguinetti, Brunella Posteraro
Zitieren
APA
Liotti, F. M., Marchetti, S., D'Onghia, S., Romano, L., Ricci, R., Sanguinetti, M., Santangelo, R., & Posteraro, B. (2025). Compelling Increase in Parvovirus B19 Infections: Analysis of Molecular Diagnostic Trends (2019–2024). Viruses, 17(4), 523. https://doi.org/10.3390/v17040523
Vancouver
Liotti FM, Marchetti S, D'Onghia S, Romano L, Ricci R, Sanguinetti M, et al. Compelling Increase in Parvovirus B19 Infections: Analysis of Molecular Diagnostic Trends (2019–2024). Viruses. 2025;17(4):523. doi:10.3390/v17040523
BibTeX
@article{Liotti2025,
author = {Liotti, Flora Marzia and Marchetti, Simona and D'Onghia, Sara and Romano, Lucio and Ricci, Rosalba and Sanguinetti, Maurizio and Santangelo, Rosaria and Posteraro, Brunella},
title = {Compelling Increase in Parvovirus B19 Infections: Analysis of Molecular Diagnostic Trends (2019–2024)},
journal = {Viruses},
year = {2025},
volume = {17},
number = {4},
pages = {523},
doi = {10.3390/v17040523}
}
EUVIMED